Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models.

Hammami I, Chen J, Murschel F, Bronte V, De Crescenzo G, Jolicoeur M.

BMC Cell Biol. 2012 Jul 4;13:18. doi: 10.1186/1471-2121-13-18.

2.

L-glutamine is a key parameter in the immunosuppression phenomenon.

Hammami I, Chen J, Bronte V, DeCrescenzo G, Jolicoeur M.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):724-9. doi: 10.1016/j.bbrc.2012.07.139. Epub 2012 Aug 1.

PMID:
22885179
3.

Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.

Husain Z, Huang Y, Seth P, Sukhatme VP.

J Immunol. 2013 Aug 1;191(3):1486-95. doi: 10.4049/jimmunol.1202702. Epub 2013 Jul 1.

4.

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, Taylor PA, Panoskaltsis-Mortari A, Serody JS, Munn DH, Tolar J, Ochoa AC, Blazar BR.

Blood. 2010 Dec 16;116(25):5738-47. doi: 10.1182/blood-2010-06-287839. Epub 2010 Aug 31.

5.

GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.

Kohanbash G, McKaveney K, Sakaki M, Ueda R, Mintz AH, Amankulor N, Fujita M, Ohlfest JR, Okada H.

Cancer Res. 2013 Nov 1;73(21):6413-23. doi: 10.1158/0008-5472.CAN-12-4124. Epub 2013 Sep 12.

6.

Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.

Kurkó J, Vida A, Ocskó T, Tryniszewska B, Rauch TA, Glant TT, Szekanecz Z, Mikecz K.

PLoS One. 2014 Nov 4;9(11):e111815. doi: 10.1371/journal.pone.0111815. eCollection 2014.

7.

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.

Lechner MG, Liebertz DJ, Epstein AL.

J Immunol. 2010 Aug 15;185(4):2273-84. doi: 10.4049/jimmunol.1000901. Epub 2010 Jul 19. Erratum in: J Immunol. 2010 Nov 1;185(9):5668.

8.

Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.

Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, Talmadge J.

Int Immunopharmacol. 2011 Jul;11(7):816-26. doi: 10.1016/j.intimp.2011.02.021. Epub 2011 Mar 2.

PMID:
21376153
9.

Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.

Kapanadze T, Gamrekelashvili J, Ma C, Chan C, Zhao F, Hewitt S, Zender L, Kapoor V, Felsher DW, Manns MP, Korangy F, Greten TF.

J Hepatol. 2013 Nov;59(5):1007-13. doi: 10.1016/j.jhep.2013.06.010. Epub 2013 Jun 22.

10.

Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.

McNiff PA, Laliberte RE, Svensson L, Pazoles CJ, Gabel CA.

Cytokine. 1995 Feb;7(2):196-208.

PMID:
7780040
11.

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE.

Int Immunopharmacol. 2009 Jul;9(7-8):937-48. doi: 10.1016/j.intimp.2009.03.021. Epub 2009 Apr 9.

PMID:
19362167
12.

Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells.

Zhang J, Wang B, Zhang W, Wei Y, Bian Z, Zhang CY, Li L, Zen K.

PLoS One. 2013 Aug 9;8(8):e70828. doi: 10.1371/journal.pone.0070828. eCollection 2013.

14.
15.

ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.

Bianchi G, Vuerich M, Pellegatti P, Marimpietri D, Emionite L, Marigo I, Bronte V, Di Virgilio F, Pistoia V, Raffaghello L.

Cell Death Dis. 2014 Mar 20;5:e1135. doi: 10.1038/cddis.2014.109.

16.

Myeloid-derived suppressor cells exhibit two bioenergetic steady-states in vitro.

Hammami I, Chen J, Bronte V, De Crescenzo G, Jolicoeur M.

J Biotechnol. 2011 Mar 10;152(1-2):43-8. doi: 10.1016/j.jbiotec.2011.01.009. Epub 2011 Jan 22.

PMID:
21262283
17.

Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.

Rosborough BR, Castellaneta A, Natarajan S, Thomson AW, Turnquist HR.

J Leukoc Biol. 2012 May;91(5):701-9. doi: 10.1189/jlb.0311119. Epub 2011 Oct 25.

18.

Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.

Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.

J Leukoc Biol. 2008 Sep;84(3):679-88. doi: 10.1189/jlb.1107729. Epub 2008 Jun 19.

19.

Poly(I:C) induce bone marrow precursor cells into myeloid-derived suppressor cells.

Liu C, Zhang C, Lu H, Cai J, Wang Z, Chen J, Liu F, Wu Z, Liu X, Sun W.

Mol Cell Biochem. 2011 Dec;358(1-2):317-23. doi: 10.1007/s11010-011-0982-3. Epub 2011 Jul 9.

PMID:
21744070
20.

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.

Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S.

J Leukoc Biol. 2010 Nov;88(5):839-48. doi: 10.1189/jlb.1209821. Epub 2010 Jun 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk